Latest News

Just 20 minutes of vigorous activity daily benefits teens


 

FROM PEDIATRICS

Any activity has value for sedentary teens

The current study suggests that counseling teens about physical activity may be less challenging for clinicians if optimal cardiorespiratory benefits can be reached with shorter bouts of activity, Michele LaBotz, MD, of Intermed Sports Medicine, South Portland, Maine, and Sarah Hoffman, DO, of Tufts University, Boston, wrote in an accompanying editorial.

The results have two key implications for pediatricians, the authors said. First, “optimal CRF can be achieved with much shorter periods of activity than previously recommended.” Second, “current ‘moderate to vigorous’ PA recommendations may not be sufficient to improve CRF in adolescents, if achieved through moderate activity only.”

However, the editorialists emphasized that, although shorter periods of higher-intensity exercise reduce the time burden for teens and families, specific education is needed to explain the extra effort involved in exercising vigorously enough for cardiorespiratory benefits.

Patients can be counseled that activity is vigorous when they start to sweat, their face gets red, and they feel short of breath and unable to talk during activity,” they explained. These sensations may be new and uncomfortable for children and teens who have been quite sedentary or used to low-intensity activity. Dr. LaBotz and Dr. Hoffman advised pediatricians to counsel patients to build intensity gradually, with “exercise snacks,” that involve several minutes of activity that become more challenging over time.

“Exercise snacks can include anything that elevates the heart rate for a minute or more, such as running up and down the stairs a few times; chasing the dog around the backyard; or just putting on some music and dancing hard,” the editorialists wrote.

“Some exercise is better than none, and extrapolating from adult data, the biggest benefit likely occurs when we can help our most sedentary and least fit patients become a bit more active, even if it falls short of currently recommended levels,” they concluded.

The study was supported by grants to various researchers from the British Heart Foundation, the Elizabeth Casson Trust, the U.K. National Institute of Health Research, the Professor Nigel Groome Studentship scheme (Oxford Brookes University), and the U.K. Department of Health. The researchers had no financial conflicts to disclose. The editorialists had no financial conflicts to disclose.

Pages

Recommended Reading

FDA authorizes Pfizer boosters for 16- and 17-year-olds
Clinician Reviews
Booster recommendations for pregnant women, teens, and other groups explained
Clinician Reviews
A pandemic silver lining? Dramatic drop in teen drug use
Clinician Reviews
iPLEDGE rollout: As frustration mounts, FDA agrees to help solve issues
Clinician Reviews
FDA to review PDE4-inhibitor roflumilast for psoriasis
Clinician Reviews
With sexually transmitted infections off the charts, California pushes at-home tests
Clinician Reviews
FDA updates status of iPLEDGE access problems
Clinician Reviews
Growth in early life may predict early puberty
Clinician Reviews
Spironolactone not linked to increased cancer risk in systematic review and meta-analysis
Clinician Reviews
Alcohol, degraded sleep related in young adults
Clinician Reviews